Approvals/TGA/AJEMNYE ustekinumab 5 mg / 1.0 mL(130 mg/26 mL) solution for intravenous infusion injection vial

Approved

STANDARD

AJEMNYE ustekinumab 5 mg / 1.0 mL(130 mg/26 mL) solution for intravenous infusion injection vial

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7308cd8eb6542603
Product Name: AJEMNYE ustekinumab 5 mg / 1.0 mL(130 mg/26 mL) solution for intravenous infusion injection vial
Artg Id: 441430
Artg Name: AJEMNYE ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2024-05-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7308cd8eb6542603

Type

Standard